Approval · Notice of Compliance 32339 · 2023
OZURDEX: Notice of Compliance 32339
Issued December 12, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32339
- Date
- December 12, 2023
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To update the Product Monograph (PM) with new safety information
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OZURDEX | Not yet assigned | — |
Medicinal ingredients
- DEXAMETHASONE 0.7 MG per MG